SARS-CoV-2 third vaccine immune response in MS patients treated with ocrelizumab
Sign Up to like & getrecommendations! Published in 2022 at "Annals of neurology"
DOI: 10.1101/2022.01.26.22269876
Abstract: The introduction of a third dose vaccination along with new variants of concerns raises questions regarding serology and T-cell responses in patients with MS (pwMS) treated with B-cell depletion who develop attenuated humoral response to… read more here.
Keywords: vaccine immune; third vaccine; response; cov third ... See more keywords